MARISSA SUDOMOIN: Open Payments
NPI 1518624360 · PAOLI, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 13 payments from 9 companies in 2025. Trend: 2023 $886 · 2024 $615 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $64 |
| Tempus AI, Inc | 1 | $64 |
| PFIZER INC. | 2 | $49 |
| Pharmacosmos Therapeutics Inc. | 2 | $42 |
| Genmab U.S., Inc. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: CALQUENCE, XT CDX, MONOFERRIC, Tivdak, INLYTA, Nubeqa, LEQVIO, NINLARO.
Industry payments across PA — which companies pay providers there.
